Insights provides context and perspective about key pharmacy trends and issues

Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2019 More
Specialty Report
Drug Pipeline
New drugs likely to offer patients more options. Key consideration for payors will be effectively balancing high — and rising — price tags with appropriate access. More
Feature
Drug Pipeline
CVS Health provides an early look at some key Breakthrough Therapies expected to be reviewed by the FDA in 2020 as well as the associated cost implications and expected approval timeframes More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2019-Q1 2020 More
Specialty Report
Drug Pipeline
New drugs to treat migraine are approaching approval and could bring relief for many patients, but they portend higher costs. Ongoing monitoring and appropriate utilization strategies can... More
Feature
Drug Pipeline
Biosimilars are a critical tool PBMs can use to help increase market competition and lower costs – we made changes to our template formularies for categories that now have biosimilars... More
Feature
Drug Pipeline
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage the pipeline More
Feature
Three teenagers eating ice cream on a pier
Drug Pipeline
Peanut allergy is the most common of childhood food allergies — and getting more common. Research presented at the annual meeting of the American College of Allergy, Asthma and Immunology (... More
Feature
Specialty Report PDF icon
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1-Q2 2019 More
Specialty Report
Group of pills icon
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2018 More
Specialty Report